Beta

    fda approve mdma for ptsd

    Before Jan 1, 2031

    fda approve mdma for ptsd. Best Yes near 56¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 56¢ · Best No: 48¢ · 1 platform

    • Kalshi: Yes 56¢ / No 48¢
    LIVE

    Before Jan 1, 2031

    Volume

    $79

    $0 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jan 1, 2031

    ~1660 days left

    Category

    Culture

    56¢CHANCE OF YES54%46%
    Yes
    56¢
    Kalshi
    No
    48¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    KalshiKalshi
    Best Yes
    Best No
    Yes
    56¢
    No
    48¢
    Vol
    $79
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2031, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 56¢: exit costs ~1.72¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jan 1, 2031
    Time Left1660 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In